Affordable Access

deepdyve-link
Publisher Website

Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

Authors
  • Strawn, Jeffrey R1
  • Compton, Scott N2
  • Robertson, Brigitte3
  • Albano, Anne Marie4
  • Hamdani, Mohamed3
  • Rynn, Moira A5
  • 1 1 Anxiety Disorders Research Program, Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine , Cincinnati, Ohio.
  • 2 2 Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine , Durham, North Carolina.
  • 3 3 Shire , Lexington, Massachusetts.
  • 4 4 New York State Psychiatric Institute, Columbia University , New York, New York.
  • 5 5 New York Presbyterian Morgan Stanley Children's Hospital, Columbia University/New York State Psychiatric Institute, New York, New York.
Type
Published Article
Journal
Journal of Child and Adolescent Psychopharmacology
Publisher
Mary Ann Liebert
Publication Date
Feb 06, 2017
Identifiers
DOI: 10.1089/cap.2016.0132
PMID: 28165762
Source
Medline
Keywords
License
Unknown

Abstract

GXR was well tolerated in pediatric subjects with GAD, SAD, and/or social anxiety disorder. ClinicalTrials.gov Identifier: NCT01470469.

Report this publication

Statistics

Seen <100 times